Variant report
Variant | esv3375021 |
---|---|
Chromosome Location | chr16:46601276-46603824 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:7)
- CpG islands (count:427)
- Chromatin interactive region (count:3)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
(count:7 , 50 per page) page:
1
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | BHLHE40 | chr16:46603093-46603220 | K562 | blood: | n/a | n/a |
2 | E2F6 | chr16:46602994-46603157 | K562 | blood: | n/a | chr16:46603014-46603023 chr16:46603044-46603053 chr16:46603084-46603093 chr16:46603141-46603153 |
3 | MAX | chr16:46602979-46603177 | K562 | blood: | n/a | chr16:46603148-46603157 |
4 | MAX | chr16:46602884-46603316 | K562 | blood: | n/a | chr16:46603251-46603266 chr16:46603148-46603157 |
5 | MYC | chr16:46603104-46603117 | K562 | blood: | n/a | n/a |
6 | POLR2A | chr16:46603040-46603071 | MCF-7 | breast: | n/a | n/a |
7 | POLR2A | chr16:46602986-46603130 | MCF-7 | breast: | n/a | n/a |
No. | Chromosome Location | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr16:46603321-46603371 | PANC-1 | pancreas: | n/a |
2 | chr16:46602737-46602787 | AG04450 | lung: | fetal |
3 | chr16:46603259-46603309 | HNPCEpiC | eye: | n/a |
4 | chr16:46603321-46603371 | RPTEC | kidney: | n/a |
5 | chr16:46603321-46603371 | ovcar-3 | ovarian: | n/a |
6 | chr16:46603321-46603371 | AG09309 | skin: | n/a |
7 | chr16:46602737-46602787 | GM12892 | blood: | n/a |
8 | chr16:46603015-46603065 | Hela-S3 | cervix: | n/a |
9 | chr16:46603021-46603071 | PANC-1 | pancreas: | n/a |
10 | chr16:46603021-46603071 | IMR90 | lung: | fetal |
11 | chr16:46603015-46603065 | GM19239 | blood: | n/a |
12 | chr16:46603259-46603309 | HAEpiC | amniotic membrane: | n/a |
13 | chr16:46603015-46603065 | Caco-2 | colon: | n/a |
14 | chr16:46603191-46603241 | AG10803 | skin: | n/a |
15 | chr16:46603259-46603309 | Hepatocyte | liver: | n/a |
16 | chr16:46603059-46603109 | HRCEpiC | kidney: | n/a |
17 | chr16:46602737-46602787 | HUVEC | blood vessel: | n/a |
18 | chr16:46603259-46603309 | IMR90 | lung: | fetal |
19 | chr16:46603321-46603371 | NB4 | blood: | n/a |
20 | chr16:46603259-46603309 | U87 | brain: | n/a |
21 | chr16:46603021-46603071 | AG09319 | gingival: | n/a |
22 | chr16:46603259-46603309 | GM12892 | blood: | n/a |
23 | chr16:46603321-46603371 | SKMC | muscle: | n/a |
24 | chr16:46603021-46603071 | SAEC | small airway: | n/a |
25 | chr16:46603191-46603241 | HCT-116 | colon: | n/a |
26 | chr16:46603015-46603065 | HCT-116 | colon: | n/a |
27 | chr16:46603059-46603109 | HCF | heart: | n/a |
28 | chr16:46603191-46603241 | IMR90 | lung: | fetal |
29 | chr16:46603015-46603065 | U87 | brain: | n/a |
30 | chr16:46603021-46603071 | U87 | brain: | n/a |
31 | chr16:46602737-46602787 | HMEC | breast: | n/a |
32 | chr16:46603191-46603241 | NH-A | brain: | n/a |
33 | chr16:46602737-46602787 | GM12878 | blood: | n/a |
34 | chr16:46603059-46603109 | HRE | kidney: | n/a |
35 | chr16:46603059-46603109 | HAEpiC | amniotic membrane: | n/a |
36 | chr16:46603015-46603065 | GM12878 | blood: | n/a |
37 | chr16:46603021-46603071 | GM12878 | blood: | n/a |
38 | chr16:46603059-46603109 | CMK | blood: | n/a |
39 | chr16:46603191-46603241 | NHDF-neo | bronchial: | n/a |
40 | chr16:46603059-46603109 | GM12892 | blood: | n/a |
41 | chr16:46603321-46603371 | HCM | heart: | n/a |
42 | chr16:46602737-46602787 | ProgFib | skin: | n/a |
43 | chr16:46603021-46603071 | NHBE | bronchial: | n/a |
44 | chr16:46603259-46603309 | PANC-1 | pancreas: | n/a |
45 | chr16:46602737-46602787 | NT2-D1 | testis: | n/a |
46 | chr16:46603321-46603371 | HCPEpiC | choroid plexus: | n/a |
47 | chr16:46603191-46603241 | PANC-1 | pancreas: | n/a |
48 | chr16:46603059-46603109 | HUVEC | blood vessel: | n/a |
49 | chr16:46603191-46603241 | HMEC | breast: | n/a |
50 | chr16:46603321-46603371 | HPAEpiC | pulmonary alveolar: | n/a |
(count:3 , 50 per page) page:
1
No data |
No data |
No data |
Variant related genes | Relation type |
---|---|
ANKRD26P1 | TF binding region |
ENSG00000260251 | TF binding region |
ENSG00000261356 | TF binding region |
ANKRD26P1 | CpG island |
ENSG00000260251 | CpG island |
ENSG00000261356 | CpG island |
ENSG00000260251 | chromatin interactions |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs542402733 | chr16:46601294-46601295 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
2 | rs560928628 | chr16:46601299-46601300 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
3 | rs142240366 | chr16:46601356-46601357 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
4 | rs56967921 | chr16:46601394-46601395 | Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
5 | rs559820310 | chr16:46601400-46601401 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
6 | rs139760923 | chr16:46601466-46601467 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
7 | rs552013370 | chr16:46601622-46601623 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
8 | rs570117938 | chr16:46601684-46601685 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
9 | rs573701037 | chr16:46601706-46601707 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
10 | rs188249419 | chr16:46601735-46601736 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
11 | rs549251510 | chr16:46601809-46601810 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
12 | rs192562365 | chr16:46601819-46601820 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
13 | rs534728466 | chr16:46601941-46601942 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
14 | rs183740173 | chr16:46601963-46601964 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
15 | rs117825712 | chr16:46601986-46601987 | Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
16 | rs187425970 | chr16:46602004-46602005 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
17 | rs578115072 | chr16:46602027-46602028 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
18 | rs556731488 | chr16:46602028-46602029 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
19 | rs12923188 | chr16:46602045-46602046 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
20 | rs575135042 | chr16:46602149-46602150 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
21 | rs12929919 | chr16:46602206-46602207 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
22 | rs545321765 | chr16:46602260-46602261 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
23 | rs542689250 | chr16:46602274-46602275 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
24 | rs59723895 | chr16:46602277-46602278 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
25 | rs12929954 | chr16:46602282-46602283 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
26 | rs12929955 | chr16:46602285-46602286 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
27 | rs71158871 | chr16:46602307-46602308 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
28 | rs374365575 | chr16:46602309-46602310 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
29 | rs10711319 | chr16:46602311-46602312 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
30 | rs55641459 | chr16:46602313-46602314 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
31 | rs7191748 | chr16:46602415-46602416 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
32 | rs539867142 | chr16:46602419-46602420 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
33 | rs144359606 | chr16:46602543-46602544 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
34 | rs578251006 | chr16:46602550-46602551 | Weak transcription Enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
35 | rs545762853 | chr16:46602633-46602634 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
36 | rs563864075 | chr16:46602639-46602640 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
37 | rs528094404 | chr16:46602706-46602707 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
38 | rs531047120 | chr16:46602708-46602709 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
39 | rs549427817 | chr16:46602727-46602728 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
40 | rs374995122 | chr16:46602736-46602737 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
41 | rs561240753 | chr16:46602790-46602791 | Weak transcription Genic enhancers | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
42 | rs528445082 | chr16:46602806-46602807 | Genic enhancers Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
43 | rs12934443 | chr16:46602819-46602820 | Genic enhancers Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs571351528 | chr16:46602830-46602831 | Genic enhancers Enhancers Weak transcription | Chromatin interactive region | 1 gene(s) | Overlapped CNVs | n/a |
45 | rs79399205 | chr16:46602842-46602843 | Genic enhancers Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs550493624 | chr16:46602865-46602866 | Genic enhancers Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs192611251 | chr16:46602881-46602882 | Genic enhancers Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
48 | rs536081666 | chr16:46602883-46602884 | Genic enhancers Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs554617679 | chr16:46602893-46602894 | Genic enhancers Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
50 | rs572864157 | chr16:46602896-46602897 | Genic enhancers Enhancers Weak transcription | TF binding region | 2 gene(s) | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Non-syndromic sensorineural hearing loss | 22037309 | CNVD |
Schizophrenia | 22958593 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Lung cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Colorectal cancer | 16272173 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Wilms tumour | 21544195 | CNVD |
Cancer | 20164920 | CNVD |
Lung cancer | 18438408 | CNVD |
Prostate cancer | 18632612 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 17850661 | CNVD |
Breast cancer | 16702952 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Prostate cancer | 19242612 | CNVD |
Cancer | 22429812 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Ewing''s sarcoma | 22429812 | CNVD |
Melanoma | 18172304 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Multiple myeloma | 21628407 | CNVD |
Autism | 19955444 | CNVD |
Schizophrenia | 19955444 | CNVD |
Renal cell carcinoma | 18765545 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Breast cancer | 21858162 | CNVD |
Chronic lymphocytic leukemia | 20421269 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Breast cancer | 21364760 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Breast cancer | 21509527 | CNVD |
Bladder cancer | 21909424 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr16:46600000-46602000 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
2 | chr16:46600400-46602800 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
3 | chr16:46601400-46603000 | Weak transcription | Right Atrium | heart |
4 | chr16:46602000-46602600 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
5 | chr16:46602600-46603600 | Genic enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
6 | chr16:46602800-46603200 | Genic enhancers | H1 Derived Mesenchymal Stem Cells | ES cell derived |
7 | chr16:46602800-46603200 | Enhancers | Fetal Heart | heart |
8 | chr16:46603000-46603200 | ZNF genes & repeats | Right Atrium | heart |
9 | chr16:46603000-46603200 | Enhancers | K562 | blood |
10 | chr16:46603200-46604600 | Weak transcription | Right Atrium | heart |
11 | chr16:46603200-46607400 | Weak transcription | H1 Derived Mesenchymal Stem Cells | ES cell derived |
12 | chr16:46603200-46607400 | Weak transcription | K562 | blood |
13 | chr16:46603600-46603800 | ZNF genes & repeats | Foreskin Fibroblast Primary Cells skin02 | Skin |
14 | chr16:46603600-46607400 | Weak transcription | iPS DF 19.11 Cell Line | embryonic stem cell |
15 | chr16:46603800-46607400 | Weak transcription | Foreskin Fibroblast Primary Cells skin02 | Skin |